Learn More
Apexbio Technology LLC Deferoxamine mesylate 138-14-7 500mg

Supplier: Apexbio Technology LLC B6068500
Deferoxamine mesylate (CAS 138-14-7) is an iron-specific chelating agent used primarily to manage acute iron poisoning It binds iron ions to form a water-soluble complex ferrioxamine thus preventing iron from participating in harmful oxidative reactions and facilitating renal excretion In rat mammary adenocarcinoma models deferoxamine mesylate treatment particularly combined with low-iron diet reduces tumor growth Additionally preoperative administration attenuates oxidative stress markers and pancreatic tissue damage by inducing HIF-1 expression in rat liver transplantation studies highlighting its utility in anticancer and cytoprotective research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.